ALT: Altimmune Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 580.94
Enterprise Value ($M) 392.41
Book Value ($M) 246.44
Book Value / Share 6.63
Price / Book 2.19
NCAV ($M) 227.38
NCAV / Share 6.12
Price / NCAV 2.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.91
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 24.96

Balance Sheet (mrq) ($M)
Current Assets 245.19
Assets 264.25
Liabilities 17.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -54.80
Net Income -49.04
Earnings Per Share Basic And Diluted -1.91
Earnings Per Share Diluted -1.91
Earnings Per Share Basic -1.91

Cash Flow Statement (mra) ($M)
Cash From Operations -34.44
Cash from Investing -72.09
Cash from Financing -72.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-01 13G Venrock Healthcare Capital Partners II, L.P. 9.99 -19.49
02-16 13G Baker Bros. Advisors Lp 5.10
02-16 13G/A Velocity Pharmaceutical Holdings Llc 5.90 2.71
02-16 13G/A D. E. Shaw & Co, L.p. 3.60 -27.95
02-08 13G/A Hudson Bay Capital Management LP 0.36 -92.89

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-05-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-02-25 10-K Annual Report – 10-K
2020-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2020-08-11 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-06-11 172,417 816,000 21.13
2021-06-10 314,064 1,415,000 22.20
2021-06-09 697,515 2,887,400 24.16
2021-06-08 115,679 739,500 15.64
2021-06-07 61,771 1,296,900 4.76

(click for more detail)

(click for list of largest short owners)

Similar Companies
ALNY – Alnylam Pharmaceuticals, Inc. ALPN – Alpine Immune Sciences Inc
ALRN – Aileron Therapeutics Inc ALXN – Alexion Pharmaceuticals, Inc.
ALXO – ALX Oncology Holdings Inc


Financial data and stock pages provided by
Fintel.io